XTNT
HealthcareXtant Medical Holdings, Inc.
$0.71
$-0.04 (-5.33%)
Jan 5, 2026
Price History (1Y)
Analysis
Xtant Medical Holdings, Inc. is a publicly traded company in the healthcare sector, specifically operating within the medical devices industry. With a market capitalization of $99.40 million and annual revenues exceeding $133 million, the company has established itself as a mid-sized player with 217 employees. The financial health of Xtant Medical Holdings, Inc. appears to be stable, with gross margins reaching 62.0% and operating margins standing at 7.6%. The company's net income (TTM) amounts to $1.75 million, while its EBITDA totals $10.90 million. Free cash flow has been substantial, totaling $9.42 million. However, the debt-to-equity ratio is significant, standing at 64.48. Cash reserves are available in the amount of $10.40 million. The valuation of Xtant Medical Holdings, Inc. indicates a relatively high price-to-earnings (P/E) ratio of 71.00, both on trailing twelve months and forward basis. Revenue growth over the past year has been substantial at 19.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Visit website →Key Statistics
- Market Cap
- $99.40M
- P/E Ratio
- 71.00
- 52-Week High
- $0.95
- 52-Week Low
- $0.34
- Avg Volume
- 295.44K
- Beta
- -0.08
Company Info
- Industry
- Medical Devices
- Exchange
- ASE
- Country
- United States
- Employees
- 217